Intezyne, a young pharmaceutical company operating out of the University of South Florida's Research Park, has struck a deal with an unnamed pharmaceutical company to accelerate bringing its cancer-treating product to market.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition